BIOATLA
BioAtla develops safer, more effective drugs for cancer using a proprietary next-generation antibody discovery and evolution platform. BioAtla is a San Diego biotech company that develops novel monoclonal antibody and cell-based therapeutics using our proprietary Conditionally Active Biologics (CAB) and Comprehensive Integrated Antibody Optimization (CIAO!) platforms. These and other proprietary technologies (protected by more than 150 issued patents and patent applications) allow them to develo... p novel biologics (CABs) that are better drugs in multiple ways including more selective targeting of cancer tissue and improved manufacturability. Improved selectivity for the tumor microenvironment, even when the target is also found in normal tissue, not only improves safety but also expands the universe of potential drug targets, enabling the treatment of previously untreatable cancers.
BIOATLA
Industry:
Biotechnology Health Care Medical
Founded:
2007-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.bioatla.com
Total Employee:
51+
Status:
Active
Contact:
1(858) 558-0708
Email Addresses:
[email protected]
Total Funding:
261.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Domain Not Resolving
Similar Organizations
BionPharma
BionPharma develops and commercializes affordable quality generics and builds strong and effective partnerships.
Pathway Genomics
Pathway Genomics is a CAP accredited global clinical lab offering genetic tests for cancer risk, drug responses, and other conditions.
Vital Therapies
Vital Therapies is a biotech company focused on developing a cell-based therapy targeting the treatment of acute liver failure.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
HBM Healthcare Investments AG
HBM Healthcare Investments AG investment in Post-IPO Equity - BioAtla
Pappas Capital
Pappas Capital investment in Post-IPO Equity - BioAtla
Sphera Global Healthcare Fund
Sphera Global Healthcare Fund investment in Post-IPO Equity - BioAtla
Deerfield
Deerfield investment in Post-IPO Equity - BioAtla
Cormorant Asset Management
Cormorant Asset Management investment in Post-IPO Equity - BioAtla
Great Point Partners
Great Point Partners investment in Post-IPO Equity - BioAtla
Ikarian Capital
Ikarian Capital investment in Post-IPO Equity - BioAtla
Hudson Bay Capital Management
Hudson Bay Capital Management investment in Post-IPO Equity - BioAtla
Soleus Capital
Soleus Capital investment in Post-IPO Equity - BioAtla
Monashee Investment Management
Monashee Investment Management investment in Post-IPO Equity - BioAtla
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2017-02-16 | Exuma Biotech | BioAtla investment in Series A - Exuma Biotech | 37 M USD |
Official Site Inspections
http://www.bioatla.com Semrush global rank: 4.17 M Semrush visits lastest month: 2.85 K
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
